Australian Clinical Labs (ASX:ACL) makes millions in profits from covid testing, and the Omicron variant has seen covid testing increase once more…

The PTB Group (ASX:PTB) share price has recovered strongly from the pandemic, but its growth plans are far from over.

Alcidion (ASX:ALC) is bolstering its product offering with its acquisition of Silverlink Software. What does it mean for shareholders?

The new Omicron variant is not causing me to panic, but I am tweaking my portfolio a little to prepare for (likely) harder times ahead.

The Alcidion share price is up around 10% after it confirmed its largest ever contract win, worth at least $23 million.

Claude Walker, Matt Joass, Andrew Page, and Kevin Fung discuss Nanosonics stock and the impact of omicron on investors.

Pro Medicus (ASX:PME) revealed significant progress with its AI Accelerator at the PME 2021 AGM and a strong contract pipeline.

Owen Raszkiewicz, Anirban Mahanti, and Claude Walker sit down to chat Pro Medicus (ASX:PME), Damstra (ASX:DTC), Tesla and Peloton stocks.

We’ve listed the company name, time of the meeting, and the link for you to join or register, below. Ask a question!

Claude Walker joins Andrew Page from Strawman, and Matt Joass and Kevin Fung from Maven funds in a casual but thought-provoking new ASX podcast.

Sometimes mature software businesses can still grow profitably via acquisition…

These three growing small-caps have all shown they can generate positive operating cashflow quite recently…

These growth stocks are still losing money, but seem to be heading in the right direction.

The Dicker Data share price is up 12% today after reporting strong demand and record year-to-date profit before tax.

One is overhyped and (possibly) very overvalued, one is a mature dividend payer, and the other is high risk, but also offers high potential rewards.

The Camplify quarterly result was very resilient in the face of lockdowns, and the share price has popped in response.

The Whispir (ASX:WSP) share price is up over 10%, reporting ARR of $56.8 million at the end of the quarter.

2.3x EV to TTM Revenue.

These five stocks all have very high quality businesses that I want to buy more shares in, if only the market would offer a slightly better price.

It’s always sad when the thesis breaks but it is best to acknowledge it.